Brief: Talis Announces Fourth Quarter And Full Year 2022 Financial Results
March 22 (Reuters) - Talis Biomedical Corp TLIS.O :
* TALIS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS
* TALIS BIOMEDICAL CORP Q4 REVENUE $300,000
* TALIS BIOMEDICAL CORP - QTRLY NET LOSS WAS $26.9 MILLION
Source text for Eikon: ID:nGNX2G3wC1
Further company coverage: TLIS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talis Biomedical
See all newsBrief: Talis Biomedical Says Nasdaq Believes Co Is 'Public Shell' And Continued Listing Of Its Common Stock Is No Longer Warranted
Brief: Talis Biomedical Says Accepting Voluntary Resignation Of Heinrich Dreismann From Board Effective August 1
Brief: Talis Biomedical Eliminates Andrew Lukowiak As President And Chief Scientific Officer
Talis Biomedical up on plans to explore strategic options, job cuts
Brief: Talis Biomedical Announces Exploration Of Strategic Alternatives And Cost Reduction Plan To Preserve Cash